Your browser doesn't support javascript.
loading
Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension.
Hauser, Stephen L; Zielman, Ronald; Das Gupta, Ayan; Xi, Jing; Stoneman, Dee; Karlsson, Goeril; Robertson, Derrick; Cohen, Jeffrey A; Kappos, Ludwig.
Afiliación
  • Hauser SL; UCSF Weill Institute for Neurosciences and Department of Neurology, University of California, San Francisco (UCSF), 1651 4th Street, Box 3126, San Francisco, CA 94143, USA.
  • Zielman R; Clinical Development, Novartis Pharma B.V., Amsterdam, The Netherlands.
  • Das Gupta A; Analytics, Novartis Healthcare Pvt. Ltd., Hyderabad, India.
  • Xi J; China Novartis Institutes for Biomedical Research Co. Ltd., Novartis, Shanghai, People's Republic of China.
  • Stoneman D; Global Medical, Novartis Pharma AG, Basel, Switzerland.
  • Karlsson G; Global Medical, Novartis Pharma AG, Basel, Switzerland.
  • Robertson D; Department of Neurology, Multiple Sclerosis Division, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Cohen JA; Department of Neurology, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA.
  • Kappos L; MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Department of Head, Spine and Neuromedicine, Biomedical and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
Mult Scler ; 29(11-12): 1452-1464, 2023 10.
Article en En | MEDLINE | ID: mdl-37691530
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos